This weeks Items

DIABETES IN CONTROL

Kristina Sandstedt, MS

Kristina Sandstedt, MS, Clinical Exercise Physiologist, Diabetes Educator

“The Role of Exercise in the Treatment of Arthritis”, Why this information is important for Diabetes Educators

Evan D. Rosen, M.D., Ph.D

Dr. Evan Rosen

 

Evan D. Rosen, M.D., Ph.D.Winning the Battle, but Losing the War

The trials of trying to get your patients to achieve ADA and AACE goals.  Click Here

Shafer Monthly Feature

“ANTIOXIDANTS”

Antioxidants have received a lot of attention in recent years, in relation to wellness and disease prevention. More studies are needed to better understand how antioxidants may affect diabetes management and treatment. Click Here

By Sherri Shafer, R.D., CDE,

View Sherri's Archives

NOMINATE YOUR CHOICE 

Best Diabetes Product or Service of the New Millennium

Medical Professionals

CHOICE AWARD

 CLICK HERE

Dr. Eric S. Freedland

 

Dr. Eric Freedland continues his series Why Focusing On Intensive Glucose Control With Drugs Alone Is Counterproductive with Part 10 Manipulating Macronutrient Ratios 

Eric S. Freedland, MD



PRINT THE NEWSLETTER

Print this weeks Newsletter Here.  

Adobe format 22 pages Download  Adobe format click here.



Dr. Thomas Burke Ph.D

Dr Thomas Burke brings us a wound care case study by Alan Kochman, PT, MS and Diane Pogmore, RN, CWOCN  

SUBSCRIBE

Subscribe to the FREE Diabetes In Control Newsletter!

Enter your email to join Diabetes In Control today!

 

HTML Text AOL
 


Item #16 

Risk for Type 1 Diabetes Greater in Overweight Children

A disturbing rise in the incidence of overweight children has occurred along with an increase of type 1 diabetes. 

In recent decades, the incidence of type 1 diabetes (DM1) in developed countries has increased for children under age 15 in general, but mostly in younger children, as reported by EURODIAB. Concurrently, a disturbing rise in the incidence of overweight children has occurred.  

We therefore searched computer and clinic records of all pediatric patients diagnosed with DM1 between 1.1.98 and 12.31.01, and examined body mass index (BMI) at diagnosis (Dx), and by <3 months post-diagnosis (P-Dx) reflecting body habitus prior to any weight loss. BMI Z-scores (BMIZ) for age >2 years, were calculated per CDC 2000 data. We included patients from physicians who admit all of their newly diagnosed diabetics to Children's Hospital of San Diego, and all DM1 patients cared for at Kaiser Permanente in San Diego. Patients from physicians who primarily admit younger or sicker patients with DM1 were excluded, as were non-resident patients.  

Also, we excluded obese patients initially treated as type 2, based on c-peptide, and clinical phenotype, who had DM1antibodies, and later became insulinopenic. Of 289 patients <15 years old (yr) in age groups 0-4, 5-9, and 10-14, there were 26.0%, 35.3%, and 38.7%, respectively. Distrbution by gender was 29.9%, 34.3%, and 35.8% in 137 girls, and 22.4%, 36.2%, and 41.4% in 152 boys, in the respective age groups. Mean (SD)[%] BMIZ at Dx and P-Dx were respectively -0.61 (1.6)[27%] and 1.09 (0.78)[86%] for ages 2-4, 0.03 (1.4)[51%] and 0.89 (1.0)[82%] for ages 5-9, -0.3 (1.2)[38%] and 0.64 (0.8)[74%] for ages 10-14. Height Z-score was about 0.25 for the 3 age groups [60%]. Mean weight gain was 15.2%, 12.5%, and 14.9%, respectively. Of all 321 pediatric patients <19 yr [1.2:1 M:F], 62.1% were Caucasian, 23.6% Hispanic, 3.4% African American, 2.5% Other, 0.9% Asian, 7.5% mixed ethnicities. BMIZ post-Dx was 1.09 in Hispanics and 0.7 in Caucasians (p <0.05). Mean weight for height P-Dx was at 80% for patients <2yr. Mean BMIZ are high P-Dx compared to expected BMIZ=0 (p <0.0001) in ages 2 to <15 yr, even though P-Dx BMI Z-scores may be underestimated, since in some cases we only had P-Dx data at <10 days. BMIZ correlated negatively with age of Dx in ages 2 to <15 yr, with r = -0.22 (spearman,p <0.001), and was significantly higher than BMIZ in 10-14 yr (p=0.01).

Conclusions: Age of Dx of DM1 no longer shows a prominent peak after age 10.  

Overweight may increase the risk of developing type1 diabetes, especially in younger children.  Endo 2002 [P2-357] The Changing Epidemiology of Childhood Type 1 Diabetes and the Obesity Epidemic 


Did You Know: 

CVD is a major complication and the leading cause of premature deathamouun people with diabetes---at least 65 percent of people with diabetes die from heart disease or stroke.  Middle-aged people with type 2 diabetes have the same high risk for heart attack as people without diabetes who already have had a heart attack.  CDC Diabetes Surveillance Report 1999

[an error occurred while processing this directive]

 

DIABETES NEWS FLASH

Dr. Jennifer Larson Feature

Dr Jennifer Larson, MD, University of Nebraska Medical Center, gave a very informative overview of Pancreas, Islet, and Kidney Transplantation: Metabolic and Endocrine Consequences, at the Endo2002 conference. We have an overview of her presentation, click here

 

TOP DIABETES STORIES

  New Drug Restores Eyesight*

Click Here

  Diabetes Management Market Predicted to Explode*

Click Here 

  Night-Light May Prevent Diabetic Eye Damage*

Click Here

  New Test Predicts Which Type 2’s Will Become Type 1’s Within 5 Years*

Click Here



FREE WEBSITE!!!

Get a FREE website for your Diabetes Organization.

 

Click Here To Learn More

NEW PRODUCT

400 needles that pierce the skin and let big molecules enter the bloodstream.  Drug delivery with this techniques offers several advantages over pills and injections. It can ensure the steady release of medication into the patient's bloodstream over long periods, improving the efficacy of a dose. It can prevent the rapid breakdown that many drugs taken orally undergo when they pass through the digestive system. Click here for more information:

 

Dr Richard K. Bernstein

This Months Corner:  

 

Dr. Richard BernsteinDr. Bernstein's Feature:  

Will eating a low-fat diet help you live longer?



INSIDE DIABETES

David Kliff 

The Pump Market - A Market in Turmoil
ADA Highlights

David Kliff, Publisher 

The Diabetic Investor

In 2 Nutrition

Generate Individualized meal plans for your patients!

See how your patients can receive over 250 personalized recipes that are ideal for individuals with diabetes, high cholesterol, heart disease and weight management problems.



NEWS FLASH !!!

Over One million US adults can't afford their drugs

Click Here

FREE CME!

Free CME

The Hyperactive Platelet in Type 2 Diabetes- sponsored by Baylor College of Medicine, Houston, Texas, offers 2 hours of AMA PRA category 1 credit   To access this free on-line activity, visit Click Here

 


Get the FREE Diabetes In Control Newsletter!

  • * Free Diabetes Related Information.
  • * Participation in Current and Future Studies
  • * Participation in Surveys (honorariums)
  • * Information that better helps your patients.
  • * Stay Current with the most updated information on treatments and medical devices.
  • * Learn about new studies......plus much more...

Simply Enter your Email Address Below to begin receiving the FREE Diabetes In Control Weekly Newsletter in your mailbox.
 

Please specify the format you can receive the newsletter in below

HTML Text AOL

Home · About Us · Advertise · Classifieds · Current News · Downloads · Education · Features · Feedback · Links · New Products · Past Newsletters · Recommend Us · Search · Show All Stories · Studies · Subscribe · Test Your Knowledge · Tools For Your Practice · Writers Archives · Search Our Archives · NewsFeed

We subscribe to the HONcode principles of the Health On the Net Foundation

©Copyright 1999-2003 Diabetes In Control

For Questions about this website click here